ACP
EW icon

Aviance Capital Partners’s Edwards Lifesciences EW Stock Holding History

Aviance Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$576K Hold
7,194
– – 0.07% 223
2025
Q4 		$613K Hold
7,194
– – 0.07% 218
2025
Q3 		$559K Hold
7,194
– – 0.07% 221
2025
Q2 		$563K Hold
7,194
– – 0.07% 212
2025
Q1 		$521K Sell
7,194
-600
-8% -$42.9K 0.07% 216
2024
Q4 		$577K Buy
7,794
+600
+8% +$42K 0.08% 200
2024
Q3 		$475K Hold
7,194
– – 0.06% 226
2024
Q2 		$665K Hold
7,194
– – 0.09% 184
2024
Q1 		$687K Buy
7,194
+2,748
+62% +$231K 0.1% 184
2023
Q4 		$339K Sell
4,446
-4
-0.1% -$278 0.07% 196
2023
Q3 		$308K Hold
4,450
– – 0.07% 204
2023
Q2 		$420K Hold
4,450
– – 0.09% 188
2023
Q1 		$368K Hold
4,450
– – 0.08% 196
2022
Q4 		$332K Hold
4,450
– – 0.08% 209
2022
Q3 		$368K Hold
4,450
– – 0.09% 192
2022
Q2 		$423K Hold
4,450
– – 0.09% 190
2022
Q1 		$524K Sell
4,450
-72
-2% -$8.08K 0.1% 182
2021
Q4 		$586K Sell
4,522
-29
-0.6% -$3.38K 0.1% 180
2021
Q3 		$515K Sell
4,551
-33
-0.7% -$3.77K 0.09% 189
2021
Q2 		$475K Buy
4,584
+1,404
+44% +$132K 0.08% 191
2021
Q1 		$266K Hold
3,180
– – 0.05% 243
2020
Q4 		$290K Hold
3,180
– – 0.06% 221
2020
Q3 		$254K Hold
3,180
– – 0.06% 222
2020
Q2 		$220K Buy
+3,180
New +$226K 0.05% 222
2020
Q1 		– Sell
-3,180
Closed -$247K – 220
2019
Q4 		$247K Hold
3,180
– – 0.06% 205
2019
Q3 		$233K Buy
+3,180
New +$223K 0.07% 202
2019
Q2 		– Sell
-3,180
Closed -$203K – 214
2019
Q1 		$203K Buy
+3,180
New +$181K 0.06% 202

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Aviance Capital Partners's EW Position: Q1 2026 in Review

Aviance Capital Partners held its Edwards Lifesciences (EW) position steady in Q1 2026 at 7,194 shares worth $576K. The position accounts for 0.07% of the portfolio, ranked #223.

Aviance Capital Partners first reported a position in EW in Q1 2019 and has held it in 27 quarters since. The position peaked at $687K in Q1 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Aviance Capital Partners held 7,194 shares of Edwards Lifesciences worth $576K as of Q1 2026.
  • Aviance Capital Partners left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.07% of Aviance Capital Partners's portfolio in Q1 2026, its #223 holding.
  • Aviance Capital Partners first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 27 quarters since.
  • Aviance Capital Partners's Edwards Lifesciences position peaked at $687K in Q1 2024.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.